Bristol-Myers Squibb (BMY) has released an update to notify the public and investors about a regulation fd disclosure.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On February 2, 2024, the Company made available a presentation on its financial and operating initiatives for the fourth quarter of 2023 and the full year, in conjunction with a conference call and webcast. The presentation, which includes non-GAAP financial information, is accompanied by reconciliations with GAAP measures and is furnished as part of a Current Report. The Company may remove the presentation from its website at any time, and the information provided is not considered filed under securities law nor is it an admission of materiality.
For further insights into BMY stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.